GB698864A - Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex - Google Patents

Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex

Info

Publication number
GB698864A
GB698864A GB6138/48A GB613848A GB698864A GB 698864 A GB698864 A GB 698864A GB 6138/48 A GB6138/48 A GB 6138/48A GB 613848 A GB613848 A GB 613848A GB 698864 A GB698864 A GB 698864A
Authority
GB
United Kingdom
Prior art keywords
riboflavin
nicotinamide
thiamine
yeast
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6138/48A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB698864A publication Critical patent/GB698864A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Compounds are made by reacting in any order adenylic acid, some or all of the essential amino acids derived from the hydrolysis of proteins and at least one of the Vitamin B components nicotinamide, thiamine and riboflavin. The adenylic acid and amino acids may be present in the form of a yeast hydrolysate, such as an enzymatic hydrolysate from which these compounds have been precipitated with acetone. Further mild hydrolysis may be necessary to convert the nucleic acid into nucleotides. The thiamine and riboflavin may also be supplied as yeast. Other proteins may be hydrolysed instead of yeast, e.g. lactalbumin, lactoglobulin, casein or blood, or alternatively the amino-acids may be supplied wholly or partially as individual compounds, especially tryptophan, histidine, arginine and lysine. Muscle adenylic acid may replace yeast adenylic acid, and either may be used in the form of a salt, e.g. of sodium, potassium, lithium, magnesium, zinc, manganese, iron, copper, calcium or cobalt; a salt may be used singly or in admixture with another salt or the free acid. The amino-acids may similarly be used as metal salts and/or salts with acids such as ascorbic, glucuronic, galacturonic or gluconic. The reaction between the components probably involves salt-formation and phosphorylation. Other substances that may be added are metallic salts, choline, pyridoxin, pantothenic acid, inositol, creatine and urea. In the examples enzymatically hydrolysed yeast is treated as follows: (1) the nucleic acid is hydrolysed with ammonia and nicotinamide added, followed by fresh yeast containing thiamine and riboflavin; (2) there are added successively adenylic acid, nicotinamide, thiamine chloride, riboflavin, pantothenic acid, pyridoxin and finally iron ammonium citrate or ferrous sulphate; (3) nicotinamide is added, followed by thiamine chloride, riboflavin, pantothenic acid, pyridoxin and choline chloride; (4) nicotinamide and fresh yeast (containing thiamine and riboflavin) are added; (5) there are added successively manganese adenylate, nicotinamide, thiamine adenylate, riboflavin adenylate, calcium pantothenate and pyridoxin; (6) nicotinamide, thiamine chloride, riboflavin, calcium pantothenate and pyridoxin are added; (7) nicotinamide, fresh yeast (containing thiamine and riboflavin), Vitamin A and Vitamin D3 are added. The materials may be reacted at room or elevated temperature. Other specified amino-acids are methionine, cysteine, cystine and tyrosine. The products of the reactions may include cocarboxylase, coenzymes I and II and carboxylase.ALSO:Compositions having therapeutic and nutritional properties comprise adenylic acid, some or all of the essential amino-acids derived from the hydrolysis of proteins and at least one of the vitamin B components nicotinamide, thiamine and riboflavin. The compounds may be mixed in solid or liquid form and in the latter case the composition may or may not be dried before administration. Some chemical action such as salt formation or phosphorylation may take place between the components. The adenylic acid and amino-acids may be present in the form of a yeast hydrolysate, such as an enzymatic hydrolysate from which these compounds have been precipitated with acetone. Further hydrolysis may be necessary to convert the nucleic acid into nucleotides. The thiamine and riboflavin may also be supplied as yeast. Other proteins may be hydrolysed instead of yeast, e.g. lactalbumin, lactoglobulin, casein or blood, or alternatively the amino-acids may be supplied wholly or partially as individual compounds, especially tryptophan, histidine, arginine and lysine. Muscle adenylic acid may replace yeast adenylic acid, and either may be used in the form of a salt, e.g. of sodium, potassium, lithium, magnesium, zinc, manganese, iron, copper, calcium or cobalt; a salt may be used singly or in admixture with another salt or the free acid. The amino-acids may similarly be used as metal salts and/or salts with acids such as ascorbic, glucuronic, galacturonic or gluconic. Other substances that may be added are metallic salts, flavouring, choline, pyridoxin, pantothenic acid, inositol, creatine and urea. Examples show the addition to enzymatically hydrolysed yeast of (1) nicotinamide and fresh yeast, containing thiamine and riboflavin; (2) adenylic acid, nicotinamide, thiamine chloride, riboflavin, pantothenic acid, pyridoxin and finally iron ammonium citrate or ferrous sulphate; (3) nicotinamide, thiamine chloride, riboflavin, pantothenic acid, pyridoxin and choline chloride; (4) manganese adenylate, nicotinamide, thiamine adenylate, riboflavin adenylate, calcium pantothenate and pyridoxin; (5) nicotinamide, thiamine chloride, riboflavin, calcium pantothenate and pyridoxin; (6) nicotinamide, fresh yeast (containing thiamine and riboflavin), vitamin A and vitamin D3. In one case the enzymatic hydrolysis is followed by ammonia treatment to split up the nucleic acid. Other specified amino-acids are methionine, cysteine, cystine and tyrosine. Chemical reaction may take place to yield cocarboxylase, coenzymes I and II and carboxylase. Details are also given of the acid hydrolysis of whey, fermentation of the lactose to give galactose and glucose, further fermentation with added yeast and final enzymatic hydrolysis of the proteins present.
GB6138/48A 1945-07-24 1948-02-27 Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex Expired GB698864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US698864XA 1945-07-24 1945-07-24

Publications (1)

Publication Number Publication Date
GB698864A true GB698864A (en) 1953-10-28

Family

ID=22091815

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6138/48A Expired GB698864A (en) 1945-07-24 1948-02-27 Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex

Country Status (1)

Country Link
GB (1) GB698864A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094038A1 (en) * 2001-05-22 2002-11-28 Bio Springer Satiating dietetic product

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002094038A1 (en) * 2001-05-22 2002-11-28 Bio Springer Satiating dietetic product
FR2825004A1 (en) * 2001-05-22 2002-11-29 Bio Springer SATIANT DIETETIC PRODUCT

Similar Documents

Publication Publication Date Title
Banga et al. Pyruvate oxidation in brain: Some dialysable components of the pyruvate oxidation system1
US3969540A (en) Enzymatically prepared metal proteinates
Sacktor The role of mitochondria in respiratory metabolism of flight muscle
Windsor et al. Gastro-intestinal absorption of heparin and synthetic heparinoids
GB1525541A (en) Process for preparing a flavouring product
JPH06287173A (en) L-form 1:1 metal methionine complex
US3966985A (en) Flavoring agent obtained by reacting a monosaccharide and a supplemented plastein
US4103003A (en) Composition for improving biologic development
GB1465308A (en) Composition and method for treating scours and/or tetany
US2749279A (en) Enzymatic production of l-glutamic acid
BR112015008066B1 (en) METHOD OF PREPARING NATURAL FLAVORING MEAT
JPS5828234A (en) Preparation of protein raw ingredient
Keilin et al. Effect of drying upon the absorption spectra of haemoglobin and its derivatives
GB1148449A (en) Process for the production of seasonings with a flavor similar to meat extract
GB698864A (en) Improvements relating to the manufacture of nutritional preparations from componentsof the vitamin b-complex
US2434715A (en) Glutamic acid-free protein hydrolysate and the production thereof
JPH0257920B2 (en)
Subbarow et al. Pantothenic acid as a factor in rat nutrition
CN100398660C (en) Method for producing compound bioactive peptide utilizing casein enzyme process
HUP9802719A2 (en) Process for preparing nicotinic acid
ES8201207A1 (en) Process for the preparation of enzymatically obtained oligomer of L-amino acid, and uses.
US2598341A (en) Manufacture of protein hydrolysates
TW202007682A (en) Method for rapidly chelating calcium by amino acid
EP0183004A1 (en) Methods for controlling the viscosity of protein hydrolysates
Ochoa Enzymic phosphorylations in invertebrate muscle